BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25847062)

  • 1. Toward predicting metastatic progression of melanoma based on gene expression data.
    Li Y; Krahn JM; Flake GP; Umbach DM; Li L
    Pigment Cell Melanoma Res; 2015 Jul; 28(4):453-63. PubMed ID: 25847062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
    Li Y; Li M; Shats I; Krahn JM; Flake GP; Umbach DM; Li X; Li L
    PLoS One; 2019; 14(6):e0218067. PubMed ID: 31199813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma.
    Huang R; Li M; Zeng Z; Zhang J; Song D; Hu P; Yan P; Xian S; Zhu X; Chang Z; Zhang J; Guo J; Yin H; Meng T; Huang Z
    Cancer Control; 2022; 29():10732748211051554. PubMed ID: 34986671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrative network-driven pipeline for systematic identification of lncRNA-associated regulatory network motifs in metastatic melanoma.
    Singh N; Eberhardt M; Wolkenhauer O; Vera J; Gupta SK
    BMC Bioinformatics; 2020 Jul; 21(1):329. PubMed ID: 32703153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction and Analysis of Skin Cancer Progression using Genomics Profiles of Patients.
    Bhalla S; Kaur H; Dhall A; Raghava GPS
    Sci Rep; 2019 Oct; 9(1):15790. PubMed ID: 31673075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative Analysis of Long Noncoding RNA (lncRNA), microRNA (miRNA) and mRNA Expression and Construction of a Competing Endogenous RNA (ceRNA) Network in Metastatic Melanoma.
    Wang LX; Wan C; Dong ZB; Wang BH; Liu HY; Li Y
    Med Sci Monit; 2019 Apr; 25():2896-2907. PubMed ID: 31004080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma.
    Jayawardana K; Schramm SJ; Tembe V; Mueller S; Thompson JF; Scolyer RA; Mann GJ; Yang J
    J Invest Dermatol; 2016 Jan; 136(1):245-254. PubMed ID: 26763444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.
    Tembe V; Schramm SJ; Stark MS; Patrick E; Jayaswal V; Tang YH; Barbour A; Hayward NK; Thompson JF; Scolyer RA; Yang YH; Mann GJ
    Pigment Cell Melanoma Res; 2015 May; 28(3):254-66. PubMed ID: 25490969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Analysis of the Prognosis-Related RNA Alternative Splicing Signals in Melanoma.
    Xue D; Cheng P; Jiang J; Ren Y; Wu D; Chen W
    Med Sci Monit; 2020 Mar; 26():e921133. PubMed ID: 32199022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic score model-based signature genes for predicting the prognosis of metastatic skin cutaneous melanoma.
    Wang J
    Math Biosci Eng; 2021 Jun; 18(5):5125-5145. PubMed ID: 34517481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-200a Regulates CDK4/6 Inhibitor Effect by Targeting CDK6 in Metastatic Melanoma.
    Bustos MA; Ono S; Marzese DM; Oyama T; Iida Y; Cheung G; Nelson N; Hsu SC; Yu Q; Hoon DSB
    J Invest Dermatol; 2017 Sep; 137(9):1955-1964. PubMed ID: 28526299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Expression of T-Box Transcription Factor Protein 21 (TBX21) in Skin Cutaneous Melanoma Predicts Better Prognosis: A Study Based on The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) Databases.
    Zhang X; Wen X; Feng N; Chen A; Yao S; Ding X; Zhang L
    Med Sci Monit; 2020 Jun; 26():e923087. PubMed ID: 32561704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel oxidative stress-related prognostic biomarkers for melanoma associated with tumor metastasis.
    Wu X; Zhao J
    Medicine (Baltimore); 2021 Feb; 100(8):e24866. PubMed ID: 33663112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing Tumor and Stromal Sources of MicroRNAs Linked to Metastasis in Cutaneous Melanoma.
    Watt K; Tyryshkin K; Renwick N; Craig AWB
    Transl Oncol; 2020 Sep; 13(9):100802. PubMed ID: 32474365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Elevated
    Bezrookove V; Nosrati M; Miller JR; De Semir D; Dar AA; Vosoughi E; Vaquero E; Sucker A; Lazar AJ; Gershenwald JE; Davies MA; Schadendorf D; Kashani-Sabet M
    Clin Cancer Res; 2018 Sep; 24(17):4119-4125. PubMed ID: 29776954
    [No Abstract]   [Full Text] [Related]  

  • 16. Downregulation of intratumoral expression of miR-205, miR-200c and miR-125b in primary human cutaneous melanomas predicts shorter survival.
    Sánchez-Sendra B; Martinez-Ciarpaglini C; González-Muñoz JF; Murgui A; Terrádez L; Monteagudo C
    Sci Rep; 2018 Nov; 8(1):17076. PubMed ID: 30459436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of B cells in cutaneous melanoma.
    Selitsky SR; Mose LE; Smith CC; Chai S; Hoadley KA; Dittmer DP; Moschos SJ; Parker JS; Vincent BG
    Genome Med; 2019 May; 11(1):36. PubMed ID: 31138334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis.
    Stark MS; Klein K; Weide B; Haydu LE; Pflugfelder A; Tang YH; Palmer JM; Whiteman DC; Scolyer RA; Mann GJ; Thompson JF; Long GV; Barbour AP; Soyer HP; Garbe C; Herington A; Pollock PM; Hayward NK
    EBioMedicine; 2015 Jul; 2(7):671-80. PubMed ID: 26288839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas.
    Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG
    Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
    Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G
    Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.